Abstract
Purpose
The purpose of the study is to review the clinical features, treatments, and outcomes of neonatal neuroblastoma (NB).
Methods
A retrospective analysis was performed on 42 patients with NB between January 1994 and December 2011.
Results
MYCN amplification was detected in nine tumor samples. The ratio of unfavorable histology to favorable histology was 1:2 in NB patients. The 5-year overall survival (OS) of NB patients was 85.7 %. The 5-year OS in patients in the operation group was 83.3 %, chemotherapy group was 83.3 %, and the “wait-and-see” group was 100 % (P = 0.04). Overall, the prognosis was favorable, except in patients with elevated MYCN amplification or vanillylmandelic acid.
Conclusions
NB patients were more sensitive and vulnerable to chemotherapy and operation. The “wait-and-see” strategy should be highlighted in the treatment of NB.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ambros IM, Benard J, Boavida M (2003) Quality assessment of genetic markers used for therapy stratification. J Clin Oncol 21:2077–2084
Azizkhan RG (2000) In: Carachi R, Azmy A, Grosfeld JL (eds) The surgery of childhood tumors. Arnold, London, pp 107–123
Brodeur GM, Pritchard J, Berthold F et al (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11:1466–1477
Chen R, Jin R, Wu L et al (2011) Reticulon 3 attenuates the clearance of cytosolic prion aggregates via inhibiting autophagy. Autophagy 7:205–216
Chou CY, Lee CN, Shih JC (2006) Prenatal diagnosis of congenital immature teratoma arising from retroperitoneum. Prenat Diagn 26:485–487
Cozzi DA, Mele E, Ceccanti S et al (2013) Long-term follow-up of the “wait and see” approach to localized perinatal adrenal neuroblastoma. J Surg 37:459–465
De Bernardi B, Gerrard M, Boni L et al (2009) Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification. J Clin Oncol 27:1034–1040
Gigliotti AR, Di Cataldo A, Sorrentino S et al (2009) Neuroblastoma in the newborn. A study of the Italian Neuroblastoma Registry. Eur J Cancer 45:3220–3227
Hsu LL, Evans AE, D’Angio GJ (1996) Hepatomegaly in neuroblastoma stage 4 s: criteria for treatment of the vulnerable neonate. Med Pediatr Oncol 27:521–528
Ikeda H, Iehara T, Tsuchida Y et al (2002) Experience with international neuroblastoma staging system and pathology classification. Br J Cancer 86:1110–1116
Katzenstein HM, Bowman LC, Brodeur GM et al (1998) Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience–a pediatric oncology group study. J Clin Oncol 16:2007–2017
Kuroda T (2011) Cellular kinetics of neuroblastoma and the role of surgery. Pediatr Surg Int 27:913–917
Michalowski MB, Rubie H, Michon J et al (2004) Neonatal localized neuroblastoma: 52 cases treated from 1990 to 1999. Arch Pediatr 11:782–788
Monclair T, Brodeur GM, Ambros PF et al (2009) The international neuroblastoma risk group (INRG) staging system: an INRG task force report. J Clin Oncol 27:298–303
Rubenstein SC, Benacerraf BR, Retik AB et al (1995) Fetal suprarenal masses: sonographic appearance and differential diagnosis. Ultrasound Obstet Gynecol 5:164–167
Schwab M, Alitalo K, Klempnauer KH et al (1983) Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305:245–248
Xue H, Horwitz JR, Smith MB et al (1995) Malignant solid tumors in neonates: a 40-year review. J Pediatr Surg 30:543–545
Yoneda A, Oue T, Imura K et al (2001) Observation of untreated patients with neuroblastoma detected by mass screening: a “wait and see” pilot study. Med Pediatr Oncol 36(1):160–162
Zhao L, Zhu Y, Wang D et al (2010) Morphine induces Beclin 1- and ATG5-dependent autophagy in human neuroblastoma SH-SY5Y cells and in the rat hippocampus. Autophagy 6:386–394
Zheng L, Terman A, Hallbeck M et al (2011) Macroautophagy-generated increase of lysosomal amyloid beta-protein mediates oxidant-induced apoptosis of cultured neuroblastoma cells. Autophagy 7:1528–1545
Acknowledgments
The authors are indebted to Dr. Xianmin Xiao, Dr. Wei Yao, and Dr. Chun Shen, who participated in our research and provided lots of suggestions to our study.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Zhou, Y., Li, K., Zheng, S. et al. Retrospective study of neuroblastoma in Chinese neonates from 1994 to 2011: an evaluation of diagnosis, treatments, and prognosis. J Cancer Res Clin Oncol 140, 83–87 (2014). https://doi.org/10.1007/s00432-013-1535-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-013-1535-9